EP2068909
Breytt FGF-21 polýpeptíð og notkun þeirra
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
19.3.2008EP published:
25.4.2012EP application number:
08732507.2
EP translation filed:
2.7.2012Grant published:
15.7.2012EPO information:
European Patent Register
Max expiry date:
18.3.2028Expiry date:
18.3.2025
Title:
MODIFIED FGF-21 POLYPEPTIDES AND THEIR USES
Timeline
Owner
Name:
Ambrx, Inc.Address:
10975 North Torrey Pines Road, Suite 100, 92037, La Jolla, CA, US
Inventor
Name:
CUJEC, Thomas, P.Address:
San Diego, CA, US
Name:
MARIANI, RobertoAddress:
San Diego, CA, US
Name:
HAYS PUTNAM, Anna-maria, A.Address:
San Diego, CA, US
Name:
KEEFE, William, M.Address:
West Hollywood, CA, US
Name:
KNUDSEN, NickAddress:
San Diego, CA, US
Name:
HO, LillianAddress:
San Diego, CA, US
Name:
PINKSTAFF, JasonAddress:
Encinitas, CA, US
Name:
KRAYNOV, VadimAddress:
San Diego, CA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
921297 PDate:
30.3.2007Country:
US
Number:
988060 PDate:
14.11.2007Country:
US
Classification
Categories:
A61K 38/18, C07K 14/50, C12N 1/21, C12N 5/10, C12N 15/18, C12N 15/63, A61K 47/48
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 25.6.2013
Expires: 18.3.2014
Payer: Árnason Faktor
Number: 7
Paid: 7.2.2014
Expires: 18.3.2015
Payer: Árnason Faktor
Number: 8
Paid: 10.2.2015
Expires: 18.3.2016
Payer: Árnason Faktor
Number: 9
Paid: 10.2.2016
Expires: 18.3.2017
Payer: Árnason Faktor
Number: 10
Paid: 10.2.2017
Expires: 18.3.2018
Payer: Árnason Faktor
Number: 11
Paid: 8.2.2018
Expires: 18.3.2019
Payer: Árnason Faktor
Number: 12
Paid: 7.2.2019
Expires: 18.3.2020
Payer: Árnason Faktor
Number: 13
Paid: 18.2.2020
Expires: 18.3.2021
Payer: Árnason Faktor ehf.
Number: 14
Paid: 8.2.2021
Expires: 18.3.2022
Payer: Árnason Faktor ehf.
Number: 15
Paid: 8.2.2022
Expires: 18.3.2023
Payer: Árnason Faktor ehf.
Number: 16
Paid: 8.2.2023
Expires: 18.3.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 23.2.2024
Expires: 18.3.2025
Payer: Árnason Faktor ehf.